M&G Investment Management LTD Intellia Therapeutics, Inc. Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$100.76 - $138.36 $1.93 Million - $2.65 Million
-19,169 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$132.37 - $176.78 $829,430 - $1.11 Million
-6,266 Reduced 24.64%
19,169 $2.57 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $1.55 Million - $4.12 Million
25,435 New
25,435 $4.12 Million

Others Institutions Holding NTLA

# of Institutions
316
Shares Held
91.7M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $722M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email